Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

Código QR

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

Manuel Cobo,1 Vanesa Gutiérrez,1 Rosa Villatoro,2 Jose Manuel Trigo,1 Inmaculada Ramos,1 Omar López,1 María Ruiz,1 Ana Godoy,1 Irene López,1 Macarena Arroyo3 1Medical Oncology Department, Hospital Universitario Málaga Regional y Virgen de la Vic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cobo M, Gutiérrez V, Villatoro R, Trigo JM, Ramos I, López O, Ruiz M, Godoy A, López I, Arroyo M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Ramucirumab NSCLC antiangiogenesis VEGF-targeted therapy second line therapy. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/9ce6e473f41f4ac5838784a2d4df92bc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety D
Publicado: (2019)

Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers
por: Rizzo M, et al.
Publicado: (2021)

Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways
por: Hyun-Dong Cho, et al.
Publicado: (2019)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Sebastian Krug, et al.
Publicado: (2021)

miRNA-21 as a novel therapeutic target in lung cancer
por: Markou A, et al.
Publicado: (2016)

Targeting MERTK and AXL in <i>EGFR</i> Mutant Non-Small Cell Lung Cancer
por: Dan Yan, et al.
Publicado: (2021)

Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes
por: Tseng YY, et al.
Publicado: (2017)

Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant
por: LEMUS,DAVID, et al.
Publicado: (2001)

Chronic lymphocytic leukemia/small lymphocytic lymphoma
por: E. A. Nikitin, et al.
Publicado: (2020)

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis
por: Yang F, et al.
Publicado: (2017)

Rate of Viral Re-Suppression and Retention to Care Among PLHIV on Second-Line Antiretroviral Therapy at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: A Retrospective Cohort Study
por: Wedajo S, et al.
Publicado: (2021)

Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse
por: ILLANES,JULIO, et al.
Publicado: (2002)

Effects of Steroidal and Non Steroidal Drugs on the Neovascularization Response Induced by Tumoral TA3 Supernatant on CAM from Chick Embryo
por: ZÚÑIGA,JORGE, et al.
Publicado: (2003)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy B, et al.
Publicado: (2020)

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib
por: Tan AC, et al.
Publicado: (2021)

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
por: Doepfner JM, et al.
Publicado: (2018)

Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study
por: Khan M, et al.
Publicado: (2021)

Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing
por: Dingbiao Li, et al.
Publicado: (2021)

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation
por: Boning Cai, et al.
Publicado: (2021)

Targeted therapy of multiple myeloma
por: Shan Zhou, et al.
Publicado: (2021)

Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
por: Anthony Vignone, et al.
Publicado: (2021)

Actividad física y cáncer de mama: un tratamiento dirigido
por: Ramírez,Karol, et al.
Publicado: (2017)

INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
por: V. P. Fokin, et al.
Publicado: (2016)

Adjuvant targeted therapy for non-small cell lung cancer
por: Konstantin K. Laktionov, et al.
Publicado: (2020)

Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds
por: Farooq,Umar, et al.
Publicado: (2019)

Small cell lung cancer transformation during antitumor therapies: A systematic review
por: Chai Xing, et al.
Publicado: (2021)

Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer
por: Minami S, et al.
Publicado: (2016)

Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
por: Li Z, et al.
Publicado: (2021)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Lei Lei, et al.
Publicado: (2021)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
por: I. V. Zlobin, et al.
Publicado: (2019)

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
por: M. I. Sekacheva, et al.
Publicado: (2020)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017)

Mitochondria-Targeting Oxygen-Sufficient Perfluorocarbon Nanoparticles for Imaging-Guided Tumor Phototherapy
por: Chen S, et al.
Publicado: (2020)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli,Meysam, et al.
Publicado: (2019)

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
por: Thierry Berghmans, et al.
Publicado: (2021)

Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang SS, et al.
Publicado: (2021)

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
por: Venturelli M, et al.
Publicado: (2018)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
por: K. K. Laktionov, et al.
Publicado: (2020)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki H, et al.
Publicado: (2017)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Alberto Fresa, et al.
Publicado: (2021)